Status:

COMPLETED

Eccentric Motor Control After SCI

Lead Sponsor:

Ohio State University

Collaborating Sponsors:

University of Notre Dame

Conditions:

Spinal Cord Injury

Eligibility:

All Genders

18-90 years

Brief Summary

This project will characterize lower extremity eccentric muscle function among individuals who have undergone locomotor training after spinal cord injury and will evaluate the effect of downhill train...

Detailed Description

Lower extremity eccentric motor control is is critically important for locomotor function but is impaired after spinal cord injury (SCI). Even after treadmill training, preliminary evidence indicates ...

Eligibility Criteria

Inclusion

  • Individuals with SCI:
  • medically approved
  • discharged from outpatient rehabilitation for 6 months
  • incomplete SCI based on ASIA impairment score (AIS C or D) at neurologic level C1-T10
  • ability to take some steps overground and on the treadmill
  • 18-90 years old.
  • ability to speak English. Note: the quality of life measures have not been validated yet in non-English speaking populations.

Exclusion

  • evidence of lower motor neuron injury in the legs
  • use of botox in the past 3 months
  • pre-existing or confounding neurologic conditions (i.e. brain injury, stroke, HIV)
  • acute deep vein thrombosis
  • skin wounds in regions where harness or hands provide support
  • pregnancy. Note: Persons who are pregnant will not be enrolled as exercise tolerance is unknown in these women with SCI.
  • cognitive conditions that preclude providing informed consent
  • ventilator-dependence as study results will be confounded by mobility limitations imposed by equipment
  • persistent orthostatic hypotension (drop of BP \>30mmHg in treadmill and harness equipment)
  • hospitalization for myocardial infarction, cardiac surgery or congestive heart failure exacerbation within 3 months of enrollment in study
  • participation in any other concurrent exercise programs.
  • Note: Use of anti-spasticity and other medications (dose, frequency) will be monitored throughout training and used as a confounding variable in the analyses.

Key Trial Info

Start Date :

June 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2019

Estimated Enrollment :

49 Patients enrolled

Trial Details

Trial ID

NCT02821845

Start Date

June 1 2015

End Date

October 1 2019

Last Update

March 22 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ohio State University

Columbus, Ohio, United States, 43210